Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COLSIO Trial: Colchicine for Obesity-Related Inflammation
NCT05017571Phase 2Completed
- Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Start
- Nov 2021
- Primary completion
- Sep 2025
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of colchicine in insulin resistance (IR), inflammation, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development. Started Nov 2021; status: completed.
02
Drugs
colchicine
03
Conditions
insulin resistance (IR)inflammation
Beyond the preview
Go deeper on NCT05017571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05017571.